MEMO1 Antibodies

Santa Cruz Biotechnology offers a broad range of MEMO1 Antibodies for research focused on understanding MEMO1 protein functions. MEMO1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MEMO1, or "Mediator of ErbB2-driven cell motility 1," plays a crucial role in cellular signaling pathways, particularly during cancer progression and metastasis. MEMO1 actively participates in regulating cell migration and proliferation, making it a significant focus in tumor biology and therapeutic research. Research has shown that MEMO1 influences multiple cellular processes essential for cancer development. Scientists worldwide are investigating MEMO1's role in various cancer types to develop more effective treatments. Understanding MEMO1's molecular mechanisms can reveal new therapeutic targets and strategies. Recent studies have highlighted MEMO1's importance in cell signaling networks and tumor progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance cancer research and contribute valuable insights to the scientific community.